drugset / Trial / NCT00451152

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

NCT00451152

Phase 2 Completed 89 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.

Timeline

Start
2007-03
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Anecortave Acetate Small molecule 0.25 ml Other
Subject Anecortave Acetate Small molecule 0.5 ml Other

Indications